Skip to content

2005 decline in UK's sexual health 'disappointing'

Zimbabwe observes a reduction in HIV prevalence, but why?

Modelling study predicts efficacy and cost-effectiveness of HIV treatment after single-dose nevirapine

AmfAR funds 'bold' viral eradication studies

US activists 'applaud' darunavir (Prezista, TMC114) pricing

Untested HIV-positive individuals account for up to 70% of sexually transmitted HIV infections in US, estimates CDC

AZT/3TC/tenofovir regimen effective first-line therapy in resource-limited settings

Should anal Pap smears be introduced for people with HIV?

Casting the first stone: the US Christian right’s war on the Global Fund